Company / Operating Margin
Day One Biopharmaceuticals, Inc. Operating Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-80.8%
FY2025
5-year range
-165.7% / -80.8%
FY2024-FY2025
Trend
+51.2%
vs FY2024
Sector context
#80 of 133
Health Care
What the data says
At -80.8%, Day One Biopharmaceuticals, Inc.'s operating margin ranks #80 of 133 in the Health Care sector.
Based on SEC 10-K filings.
-80.8% in FY2025.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#80 of 133 in Health CareTop 60% of 133This company -80.8% Sector average -914.0%
▼
+91.2% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 51.2% year-over-year.
- Currently 833.2pp above the Health Care sector average.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -80.8% | +51.2% |
| FY2024 | -165.7% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026